Skip to main content

Table 1 Univariate analysis of associations of clinical factors with overall survival. P-value was calculated using log rank sum test. Hazard Ratio (HR) > 1 indicates negative correlation with OS.

From: Integrated analysis of molecular and clinical features associated with overall survival in melanoma patients with brain metastasis

Feature

# (% or range)

HR (95% CI)

P value

Follow-up from initial surgical resection, median (range), months (n = 74)

7.8 (0.8–132.6)

NA (Outcome Variable)

NA

Normalized age at initial surgery, median (range), years (n = 69, Unknown = 5)

54 (26–76)

1.04 (0.81, 1.34)

0.741

Gender

 Female, n (%)

 Male, n (%)

31 (41. 9%)

43 (58.1%)

1 (Reference)

1.1 (0.66, 1.82)

0.718

Pre-operative KPS, median (range)

(n = 60, Unknown = 14)

90 (20–100)

0.98 (0.96, 0.99)

0.006

KPS above 70

 No, n (%)

 Yes, n (%)

 Unknown, n (%)

8 (10.8%)

52 (70.3%)

14 (18.9%)

1 (Reference)

0.41 (0.19, 0.89)

0.025

Post-operative radiation

 No, n (%)

 Yes, n (%)

39 (52.7%)

35 (47.3%)

1 (Reference)

1.13 (0.69, 1.87)

0.627

Extent of resection

 Gross Total Resection, n (%)

 Subtotal Resection, n (%)

 Unknown, n (%)

52 (70.3%)

9 (12.2%)

13 (17.5%)

1 (Reference)

0.86 (0.39, 1.92)

0.72

Presence of more than one MBM

 No, n (%)

 Yes, n (%)

 Unknown, n (%)

33 (44.6%)

29 (39.2%)

12 (16.2%)

1 (Reference)

0.79 (0.46, 1.37)

0.402

Presence of Extracranial disease at the time of craniotomy

 No, n (%)

 Yes, n (%)

 Unknown, n (%)

19 (25.7%)

52 (70.3%)

3 (4.0%)

1 (Reference)

2.22 (1.22, 4.03)

0.008

Extracranial stage IV disease status

 Controlled, n (%)

 Uncontrolled, n (%)

 Unknown, n (%)

32 (43.2%)

37 (50.0%)

5 (6.68%)

1 (Reference)

2.13 (1.25, 3.63)

0.006

Serum LDH

 Elevated, n (%)

 Not Elevated, n (%)

17 (28.3%)

43 (71.7%)

1 (Reference)

0.53 (0.28, 0.98)

0.042